Concurrent chemoimmunotherapy in metastatic clear cell sarcoma: A case report

Salvatore Lauro, Francesca Bordin, Luciana Trasatti, Gaetano Lanzetta, Carlo Delia Rocca, Luigi Frati

Research output: Contribution to journalArticlepeer-review


Clear cell sarcoma is a rare tumor with a poor prognosis. The therapeutic approach in the metastatic disease stage is controversial: to the authors' knowledge the use of concurrent chemoimmunotherapy has not been previously reported. We present a case of a 57-year-old male with metastatic clear cell sarcoma treated simultaneously with subcutaneous interferon-α 2b and six courses of chemotherapy according to the CyVEDIC regimen. Disease stabilization lasting 17 months was achieved.

Original languageEnglish
Pages (from-to)512-514
Number of pages3
Issue number6
Publication statusPublished - Nov 1999


  • Chemoimmunotherapy
  • Clear cell sarcoma

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Concurrent chemoimmunotherapy in metastatic clear cell sarcoma: A case report'. Together they form a unique fingerprint.

Cite this